脂質(zhì)包埋編碼Cas9的信使RNA（mRNA）
| 【Numbering】BKMC128003 | 【CAS】CAS | ||
| 【Item No.】BKMC128003-2 | 【specification】 | ||
|
|||
Name: Senger RNA (mRNA) encoding Cas 9
Composition: Lip Cas9 mRNA sgRNA
Grain size: ~700nm
Application: Sickle cell disease, Duchenne muscular dystrophy, Huntington's disease, and even many cancers
Storage conditions: -4℃
Other instructions: a shelf life of half a year in the sealed state [main advantage] The unique feature is that they are made of synthetic lipids containing disulfide bonds in the fat chain. When these nanoparticles enter the cell, the environment in the cell destroys the disulfide bonds and breaks them apart, resulting in the rapid and efficient release of their inclusions into the cell.
Message
Composition: Lip Cas9 mRNA sgRNA
Grain size: ~700nm
Application: Sickle cell disease, Duchenne muscular dystrophy, Huntington's disease, and even many cancers
Storage conditions: -4℃
Other instructions: a shelf life of half a year in the sealed state [main advantage] The unique feature is that they are made of synthetic lipids containing disulfide bonds in the fat chain. When these nanoparticles enter the cell, the environment in the cell destroys the disulfide bonds and breaks them apart, resulting in the rapid and efficient release of their inclusions into the cell.
Title:Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles
Article link:https://www.pharnexcloud.com/zixun/sx_5
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance |
Message
|
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance.The website pictures are from the Internet. The pictures are for reference only. Please take the real object as the standard. In case of infringement, please contact us to delete them immediately. |
Previous： the end...
